Adam Kaplin
Director/Board Member bij Cody Unser First Step Foundation
Vermogen: 220 000 $ op 31-03-2024
Profiel
Adam Kaplin is the founder of MIRA Pharmaceuticals, Inc., which was founded in 2020.
He held the title of President & Chief Science Officer from 2022 to 2024.
Dr. Kaplin is also currently working at The Johns Hopkins University as the Director of the Johns Hopkins Ketamine Clinic since 2002.
Additionally, he is the Director of Cody Unser First Step Foundation since 2005.
Previously, Dr. Kaplin worked as the Chief Scientific Officer at MyMD Pharmaceuticals, Inc. from 2020 to 2024.
Dr. Kaplin obtained his doctorate degree from The Johns Hopkins University in 1996 and his undergraduate degree from Yale University in 1988.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 03-08-2023 | 200 000 ( 1.35% ) | 220 000 $ | 31-03-2024 | |
| 29-03-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Adam Kaplin
| Bedrijven | Functie | Begin |
|---|---|---|
| The Johns Hopkins University | Corporate Officer/Principal | 01-01-2002 |
| Cody Unser First Step Foundation | Director/Board Member | 01-01-2005 |
Eerdere bekende functies van Adam Kaplin
| Bedrijven | Functie | Einde |
|---|---|---|
| MYMD PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 15-04-2024 |
| MIRA PHARMACEUTICALS, INC. | Founder | 07-03-2024 |
Opleiding van Adam Kaplin
| The Johns Hopkins University | Doctorate Degree |
| Yale University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MYMD PHARMACEUTICALS, INC. | Health Technology |
| MIRA PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
| Cody Unser First Step Foundation |
